*Result*: A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): a structured summary of a study protocol for a randomised controlled trial
*Author/editor-in-chief*:
*Publication*:
Freiburg : Universität, 2020
*Physical description scale*:
Online-Ressource
*Format*:
*Language*:
*eng*
*Notes*:
Trials
21, 1 (2020) , 470, ISSN: 1745-6215
21, 1 (2020) , 470, ISSN: 1745-6215
*Subject Added Keywords*:
*DOI*:
10.1186/s13063-020-04447-3